Brief: Mirum Pharmaceuticals Q2 Product Sales USD 176.243 Million
05/08/2026 21:02
BRIEF-Mirum Pharmaceuticals Q2 Product Sales USD 176.243 Million Aug 05 (Reuters) - Mirum Pharmaceuticals Q2 operating expenses USD 218.78 million.
- Q2 operating income USD -42.537 million
- Q2 net income USD -67.227 million
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX